Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

Vaccination for COVID-19

Checked: 08-04-2022 by Rob.Adams Next Review: 28-10-2022

Mass Vaccination

Please see Teamnet page for Mass Vaccinations for latest advice about COVID-19 vaccination.

Latest patient advice and priority groups for vaccination can also be found on the NHS Coronavirus (COVID-19) Vaccination page.

Vaccine allergy

Up to date information about COVID vaccines including information about adverse reactions and contraindications, can be found in the Green Book (chapter 14a) 

Severe allergic reactions to COVID-19 vaccination are extremely rare.

All vaccinators undergo training on the different vaccines currently being used, which includes information about reactions to the vaccine, and contra-indications for patients who may be more at risk of anaphylaxis.

If a patient has a severe or unexpected allergic reaction then please refer to Immunology and Allergy advice and guidance page. If advice from an allergy specialist is advised then please use the COVID vaccine allergy advice and guidance service. Details on this pathway and information required by the specialist can be found on the Immunology and Allergy advice and guidance page. This is the only route for advice and management of these patients and other referral routes should not be used.

Pregnancy, breastfeeding and vaccination

Guidance for health care professionals

Please see the latest guidance regarding vaccination during pregnancy in the following documents from the RCOG:

COVID-19 infection in pregnancy

Guidance for the general public

Please see the following guidelines for the general public from the NHS:

Pregnancy, Breast Feeding, Fertility and COVID-19 vaccination

The RCOG has also produced some FAQs:

Covid-19 vaccines, pregnancy and breastfeeding FAQs

COVID vaccine for children

Guidance for health care professionals

COVID -19 vaccination in children is included in the Green Book (chapter 14a) - (pages 19-26)

Guidance for the general public

See guidelines from the NHS for the general public regarding COVID-19 vaccination in children

Post-vaccination headache

Please find attached document on Management of headaches v2 (19.04.21) from the BNSSG Clinical Delivery Group. 

It now includes the instruction to inform the patient's GP surgery or OOH service about any lab investigation.

New NICE guidelines 29.7.21

COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT)

Myocarditis and Pericarditis following COVID-19 vaccination

Myocarditis and pericarditis after COVID-19 is very rare 

  • most patients who develop symptoms do so within a week of vaccination
  • patients who develop symptoms have usually been vaccinated with a mRNA vaccine (Pfizer or Moderna)
  • myocarditis and pericarditis following vaccination is usually mild or stable and patients typically recover fully without medical treatment
  • myocarditis – a very small number of those with this condition have been admitted to hospital. 

Please see further information and guidance below if this is suspected:

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals - GOV.UK (

Vaccination guidance after treatment for Covid-19 for adults

Please see the Formulary pages for BNSSG Vaccination Guidance after Treatment for COVID-19


Green Book (chapter 14a)

COVID vaccine alternative languages hub available on the Healthier Together website

Please find attached a link to the new alternative language hub developed for the programme. Not having English as a first language is the biggest indicator of low COVID-19 vaccine uptake. 

The hub contains trusted resources in the most commonly spoken languages spoken in BNSSG plus BSL (in alphabetical order).

A useful comparison guide to the different vaccines can be viewed on the following website: Covid-19 Vaccines: The Ultimate 2022 Guide to Every Vaccine (